Chemical Compound

Valdecoxib

CAS Registry Number 181695-72-7
Valdecoxib chemical structure
Primary Record

Valdecoxib

In stock
3,317 g
Purity
98.5 %
CAS
181695-72-7

Compound Identifiers & Properties

CAS
181695-72-7
PubChem CID
119607
SMILES
CC1=C(C(=NO1)C2=CC=CC=C2)C3=CC=C(C=C3)S(=O)(=O)N
Canonical SMILES
Cc1onc(-c2ccccc2)c1-c1ccc(S(N)(=O)=O)cc1

Names & Synonyms

  • Valdecoxib
  • Bextra
  • 181695-72-7
  • Valdyn
  • Kudeq
  • valdecoxibum
  • Valecoxib
  • Valdecoxib [USAN]
  • Vatdecoxib
  • Valdecoxib/
  • 4-(5-methyl-3-phenylisoxazol-4-yl)benzenesulfonamide
  • Bextra(Valdecoxib)
  • SC-65872
  • Parecoxib Impurity 2
  • SC 65872
  • Bextra (TN)
  • Valdecoxib-13C2,15N
  • Valdecoxib (Standard)
  • Valdecoxib (USAN/INN)
  • Spectrum_001747
  • 2aw1
  • CHEMBL865
  • RefChem:56405
  • VALDECOXIB [MI]
  • Valdecoxib-13C2, 15N
  • VALDECOXIB [INN]
  • Spectrum2_000508
  • Spectrum3_001001
  • Spectrum4_001129
  • Spectrum5_001476
  • VALDECOXIB [HSDB]
  • 4-(5-Methyl-3-phenyl-4-isoxazolyl)benzenesulfonamide
  • Pfizer brand of valdecoxib
  • DTXSID6044226
  • VALDECOXIB [VANDF]
  • D0L6DA
  • HSDB 7302
  • Valdecoxib [USAN:INN:BAN]
  • SCHEMBL3356
  • VALDECOXIB [MART.]
  • Benzenesulfonamide, 4-(5-methyl-3-phenyl-4-isoxazolyl)-
  • LNPDTQAFDNKSHK-UHFFFAOYSA-N
  • VALDECOXIB [WHO-DD]
  • MFCD00950568
  • YM-974
  • BSPBio_002721
  • DTXCID4024226
  • KBioGR_001617
  • KBioSS_002227
  • C16H14N2O3S
  • cc-671
  • CHEBI:63634
  • MLS000759433
  • MLS001165699
  • MLS001195631
  • MLS001424105
  • NSC-759846
  • SPECTRUM1504302
  • VALDECOXIB [EMA EPAR]
  • SPBio_000435
  • AC1L3P42
  • cid_119607
  • GTPL2894
  • orb1310822
  • UNII-2919279Q3W
  • ZINC6694
  • VALDECOXIB [ORANGE BOOK]
  • Valdecoxib, >=98% (HPLC)
  • BDBM13063
  • CTK8E7482
  • ERK5-3D04
  • KBio2_002227
  • KBio2_004795
  • KBio2_007363
  • KBio3_001941
  • KS-00000XKX
  • EX-A241
  • M01AH03
  • MSK8007
  • Valdecoxib m-Sulfonamide Impurity
  • GLXC-05758
  • HMS1922J21
  • HMS2051P07
  • HMS2232P23
  • HMS3372D12
  • HMS3393P07
  • HMS3652I04
  • HMS3715L18
  • HMS3885O20
  • HMS5082A04
  • Pharmakon1600-01504302
  • 4-(5-methyl-3-phenyl-1,2-oxazol-4-yl)benzenesulfonamide
  • AMY31078
  • BCP02419
  • ND-0214
  • 4-(5-methyl-3-phenyl-1,2-oxazol-4-yl)benzene-1-sulfonamide
  • p-(5-Methyl-3-phenyl-4-isoxazolyl)benzenesulfonamide
  • Tox21_111438
  • ABP000351
  • AC-120
  • C16-H14-N2-O3-S
  • CCG-39589
  • CID119607
  • EBC-26753
  • HY-15762R
  • NCGC00095129-01
  • NP3137
  • NSC759846
  • s4049
  • 2919279Q3W
  • AKOS000280920
  • Tox21_111438_1
  • 4-(5-methyl-3-phenyl-isoxazol-4-yl)benzenesulfonamide
  • ACN-053782
  • CID:119607
  • CS-1674
  • CS-W-00221
  • DB00580
  • FV28650
  • NC00184
  • NSC 759846
  • RL02316
  • SB19519
  • MRF-0000216
  • NCGC00095129-02
  • NCGC00095129-03
  • NCGC00095129-06
  • Valdecoxib, analytical reference material
  • AJ-08285
  • AK122221
  • AN-16123
  • BC209355
  • CPD000466327
  • HY-15762
  • SAM001246603
  • SC-19235
  • SID:53789038
  • SMR000466327
  • SY115891
  • ZB000648
  • 3-(4-Methoxyphenyl)-1-phenyl-1H-pyrazole
  • AB0125618
  • DB-044435
  • LS-173713
  • RT-016210
  • UNM-0000305814
  • 4-(5-methyl-3-phenyl-4-isoxazolyl) benzenesulfonamide
  • 4CH-003246
  • B1459
  • CAS-181695-72-7
  • FT-0631199
  • FT-0675755
  • NS00009831
  • ST24042991
  • SW197564-2
  • J1.302.764A
  • PARECOXIB IMPURITY F (REFERENCE GRADE)
  • A13342
  • C21552
  • D02709
  • 4-(Methyl-3-phenyl-isoxazol-4-yl)-benzenesulfonamide
  • AB00639996-08
  • AB00639996_10
  • EN300-7393031
  • 3-Phenyl-4-(4-sulfamoylphenyl)-5-methylisoxazole
  • 695V727
  • A812629
  • C406224
  • F320060
  • Q347613
  • SR-01000759421
  • 1189428-23-6
  • SR-01000759421-4
  • 4-(3-Phenyl-5-methyl-4-isoxazolyl)benzenesulfonamide
  • 4-(3-Phenyl-5-methylisoxazole-4-yl)benzenesulfonamide
  • 4-[3-Phenyl-5-methylisoxazole-4-yl]benzenesulfonamide
  • 4-[5-methyl-3-phenylisoxazol-4-yl]benzenesulfonamide
  • 4-[5-methyl-3-phenylisoxazol-4-yl]benzensulfonamide
  • BRD-K12994359-001-02-8
  • BRD-K12994359-001-14-3
  • BRD-K12994359-001-18-4
  • I14-44902
  • 4-(5-Methyl-3-phenyl-isoxazol-4-yl)-benzenesulfonamide
  • COX
  • Valdecoxib, 98%, a COX-2 selective inhibitor - 1G 1g
  • N0001-010445
  • Benzenesulfonamide, 4-(5-methyl-3-phenyl-4-isoxazolyl)-(9CI)
  • Benzenesulfonamide, 4-(5-methyl-3-phenyl-4-isoxazolyl)- (9CI)
  • Benzenesulfonamide, 4-?(5-?methyl-?3-?phenyl-?4-?isoxazolyl)?-
  • 4-[3-Phenyl-5-(trideuteriomethyl)-1,2-oxazol-4-yl]benzenesulfonamide
  • 4-(5-(113C)methyl-3-phenyl-(513C,215N)1,2-oxazol-4-yl)benzenesulfonamide
  • 4-(5-Methyl-3-phenyl-4-isoxazolyl)benzenesulfonamide; 4-(5-Methyl-3-phenylisoxazol-4-yl)benzenesulfonamide; Bextra; SC 65872; Valdecoxib; Valecoxib; Valus; Valz; Vx 2; Benzenesulfonamide, 4-(5-methyl-3-phenyl-4-isoxazolyl)-
  • 448-010-8
  • InChI=1/C16H14N2O3S/c1-11-15(12-7-9-14(10-8-12)22(17,19)20)16(18-21-11)13-5-3-2-4-6-13/h2-10H,1H3,(H2,17,19,20
  • VLX